CORD-19:c654596857bce9cdd64ffc51842048643107348c / 480819-481020 JSONTXT

Annnotations TAB JSON ListView MergeView

CORD-19-Sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T4109 0-71 Sentence denotes University of Bonn, Pharmaceutical Microbiology, Bonn, Germany Purpose:
TextSentencer_T4110 72-201 Sentence denotes The intravenous form (IV) of 400 mg Moxifloxacin (MOX), one of the newer fluoroquinolones, has been recently approved by the FDA.
T30282 0-71 Sentence denotes University of Bonn, Pharmaceutical Microbiology, Bonn, Germany Purpose:
T32271 72-201 Sentence denotes The intravenous form (IV) of 400 mg Moxifloxacin (MOX), one of the newer fluoroquinolones, has been recently approved by the FDA.

Epistemic_Statements

Id Subject Object Predicate Lexical cue
T610 0-201 Epistemic_statement denotes University of Bonn, Pharmaceutical Microbiology, Bonn, Germany Purpose: The intravenous form (IV) of 400 mg Moxifloxacin (MOX), one of the newer fluoroquinolones, has been recently approved by the FDA.

CORD-19_Custom_license_subset

Id Subject Object Predicate Lexical cue
T281 0-71 Sentence denotes University of Bonn, Pharmaceutical Microbiology, Bonn, Germany Purpose:
T282 72-201 Sentence denotes The intravenous form (IV) of 400 mg Moxifloxacin (MOX), one of the newer fluoroquinolones, has been recently approved by the FDA.